Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.67 |
| ▸ | PPARD | Q03181 | 4/20 | 0.67 |
| ▸ | PPARA | Q07869 | 4/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.67 |
| ▸ | F7 | P08709 | 4/20 | 0.67 |
| ▸ | F3 | P13726 | 4/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.67 |
| ▸ | FABP4 | P15090 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.67 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26461188 | 1.00 | PPARG (0.67) | PPARGALDH1A1PPARDPPARAKDM4E | |
| SCHEMBL15908481 | 1.00 | PPARG (0.67) | PPARGALDH1A1PPARDPPARAKDM4E | |
| SCHEMBL12261544 | 0.98 | ALDH1A1 (0.68) | PPARGALDH1A1PPARDPPARAKDM4E | |
| SCHEMBL1784610 | 0.94 | PPARG (0.61) | PPARGALDH1A1PPARDPPARAKDM4E | |
| SCHEMBL11502529 | 0.94 | PPARG (0.61) | PPARGALDH1A1PPARDPPARAKDM4E | |
| SCHEMBL1784609 | 0.94 | PPARG (0.61) | PPARGALDH1A1PPARDPPARAKDM4E | |
| SCHEMBL3670918 | 0.92 | PPARG (0.72) | PPARGALDH1A1PPARDPPARAKDM4E | |
| SCHEMBL10740199 | 0.92 | PPARG (0.72) | PPARGALDH1A1PPARDPPARAKDM4E | |
| SCHEMBL3670919 | 0.92 | PPARG (0.72) | PPARGALDH1A1PPARDPPARAKDM4E | |
| SCHEMBL12629207 | 0.92 | PPARG (0.72) | PPARGALDH1A1PPARDPPARAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4321614-A1 | METHOD FOR PREPARING OLIGODENDROCYTES AND USE | Shenzhen Exoneuglia Biomedical Technology Co., Ltd. (CN) | 2024-02-14 | — | — | EP | claimed |
| WO-2023165062-A1 | METHOD FOR PREPARING OLIGODENDROCYTES AND USE | 深圳市夏同生物医药科技有限公司 | 2023-09-07 | — | — | WO | claimed |
| CN-114262686-A | Preparation method and application of oligodendrocyte | 深圳市夏同生物医药科技有限公司 | 2022-04-01 | — | — | CN | claimed |
| US-20240226255-A9 | COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-07-11 | — | — | US | disclosed |
| US-20240207212-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION | UNIVERSITY OF MASSACHUSETTS | 2024-06-27 | — | — | US | disclosed |
| US-20240131130-A1 | COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS | UNIV CALIFORNIA (US) | 2024-04-25 | — | — | US | disclosed |
| EP-4321614-A1 | METHOD FOR PREPARING OLIGODENDROCYTES AND USE | Shenzhen Exoneuglia Biomedical Technology Co., Ltd. (CN) | 2024-02-14 | — | — | EP | disclosed |
| US-11865093-B2 | Methods and compositions for treating inflammation | UNIVERSITY OF MASSACHUSETTS (US) | 2024-01-09 | — | — | US | disclosed |
| EP-4294414-A1 | COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS | The Regents of The University of California (US) | 2023-12-27 | — | — | EP | disclosed |
| WO-2023165062-A1 | METHOD FOR PREPARING OLIGODENDROCYTES AND USE | 深圳市夏同生物医药科技有限公司 | 2023-09-07 | — | — | WO | disclosed |
| US-20230048743-A1 | Structures for Reducing Antibody-Lipase Binding | GENENTECH INC. (US) | 2023-02-16 | — | — | US | disclosed |
| WO-1994011370-A1 | SUBSTITUTED AMINO ALKYL COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1994-05-26 | — | — | WO | disclosed |
| WO-1994011001-A1 | HYDROXYL-CONTAINING COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1994-05-26 | — | — | WO | disclosed |
| WO-1994006431-A1 | NOVEL EPOXIDE-CONTAINING COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1994-03-31 | — | — | WO | disclosed |
| EP-0584347-A1 | ENANTIOMERIC HYDROXYLATED XANTHINE COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1994-03-02 | — | — | EP | disclosed |
| US-5288721-A | Substituted epoxyalkyl xanthines | CELL THERAPEUTICS, INC. (US) | 1994-02-22 | — | — | US | disclosed |
| EP-0573617-A4 | — | — | 1994-02-09 | — | — | EP | disclosed |
| EP-0573617-A1 | MODULATION OF CELLULAR RESPONSE TO EXTERNAL STIMULI | Fred Hutchinson Cancer Research Center (US) | 1993-12-15 | — | — | EP | disclosed |
| WO-1993017684-A2 | ENANTIOMERIC HYDROXYLATED XANTHINE COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1993-09-16 | — | — | WO | disclosed |
| WO-1992021344-A2 | MODULATION OF CELLULAR RESPONSE TO EXTERNAL STIMULI | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 1992-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11865093-B2 | Methods and compositions for treating inflammation | ABCC3, ABCC1, ABCE1 | PPARG 221/4885ALDH1A1 1747/4885PPARD 901/4885 |
| US-20240207212-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION | ABCC3, ABCC1, ABCE1 | PPARG 221/4885ALDH1A1 1747/4885PPARD 901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.